Crossmark

Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12885-025-15183-9

Published Online: 2026-01-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guastella, Riccardo

Perri, Giampaolo

Bassi, Domenico

Canitano, Nicola

Padoan, Virginia

Grandi, Samuele

Pellegrini, Riccardo

Procaccio, Letizia

Bergamo, Francesca

Lonardi, Sara

Carandina, Riccardo

Gringeri, Enrico

Marchegiani, Giovanni

Cillo, Umberto
License Information

Text and Data Mining valid from 2026-01-12

Version of Record valid from 2026-01-12
More Information

Article History

Received: 12 March 2025

Accepted: 10 October 2025

First Online: 12 January 2026

Declarations

:

: This study was approved by the “Comitato Etico Territoriale Area Centro-Est Veneto” with reference number 5989/AO/24 on 06/06/2024. Written informed consent will be obtained from all study participants before enrollment, ensuring their full understanding of the study procedures, potential risks, and benefits. The study adheres to the principles outlined in the Declaration of Helsinki and follows national and institutional ethical guidelines.

: Not applicable. This manuscript does not contain any individual person’s data in any form (including images or videos) requiring explicit consent for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below